Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.

Monitoring for adverse effects in clinical treatments is crucial.

Hair and nail conditions can stabilize or improve over time, and new treatments show promise.

After chemotherapy for a gestational trophoblastic tumor, normal pregnancy rates are possible, but there's a slightly higher risk of the tumor reoccurring in future pregnancies.

Vaginal surgeries generally did not significantly change women's sexual quality of life.

Androgenetic alopecia is not caused by low iron levels.

Diode laser is more effective but more painful than intense pulsed light for hair removal.

Baricitinib shows promise in improving frontal fibrosing alopecia symptoms.

Sunekos® effectively improves labia majora appearance and is well-tolerated.

Linalool in personal care products may worsen frontal fibrosing alopecia by damaging hair follicle stem cells and triggering harmful immune responses.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

The document says doctors should identify and treat Frontal fibrosing alopecia medically before considering surgery, as treatments often don't work well.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

The report recommends personalized treatment for women's sexual dysfunctions and more research on effective therapies.

Iron deficiency may be related to hair loss, but there's not enough evidence to recommend iron screening or supplements for all hair loss patients.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Hormones like estrogen, testosterone, progesterone, and prolactin play complex roles in female sexual function, with testosterone potentially improving sexual desire, arousal, and satisfaction. However, more research is needed to establish safe and effective hormone treatments for female sexual dysfunction.

Gynecologists should provide comprehensive care for transgender patients, including mental health evaluation, hormone therapy, and surgical options, while monitoring for side effects and ensuring patient safety.

Women have unique stroke risks due to hormones, contraceptives, pregnancy, and menopause.

Menopause significantly reduces skin collagen, leading to thinner, less elastic skin, and hormone replacement may help but requires careful consideration.

Menopause-related hormonal changes affect hair but are not the only cause of hair changes in middle-aged women.

Women with androgen excess, especially those with PCOS, have a much higher risk of heart disease and stroke.

Menopause affects hair and skin; more research needed for treatment.

Testing for CAG repeat polymorphism in the androgen receptor gene is not currently recommended for managing hypogonadism.

Women with scarring alopecia have a lower quality of life and more anxiety and depression than those with non-scarring alopecia.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Ovarian function was similar in both treatment groups, but both caused excessive hair growth.

Inflammation in rheumatoid arthritis increases steroid activation in cells, reducing inflammation.

Antiandrogen therapies are beneficial for treating skin and hair conditions related to androgen levels.